November 2019 ADVANCING OUTCOMES OF ESOPHAGEAL CANCER THROUGH EARLY DETECTION, CLINICAL TRIALS, MINIMALLY INVASIVE SURGERY AND MOREFeaturing: David Odell, MD
Episode SummaryEsophageal cancer is the fastest growing malignancy in the United States that often has no symptoms in its early stages. David Odell, MD, associate professor of Thoracic Surgery at Northwestern Medicine and the Robert H. Lurie Comprehensive Cancer Center at Northwestern University, specializes in minimally invasive treatment of esophageal cancer. Tune in to hear him share more about Northwestern Medicine's comprehensive approach to treating esophageal cancer, the latest technology and his team's work to development of protocols for early detection.
|
Dr. David Odell is a fellowship-trained general thoracic surgeon. His clinical practice is focused on thoracic oncology, dovetailing with his research interest in healthcare systems and quality improvement in cancer care. Dr. Odell has developed expertise in thoracic oncology with over 20 years of training and experience.
Refer a PatientNorthwestern Medicine welcomes the opportunity to partner with you in caring for your patients.
|
You May Also Like
September 2020 |
October 2019 |
March 2019 |